Cck2 Cck2B Receptor Agonist Supplier Research Service

Bb₂R Ligand Research Reagent

Cck2 Cck2B Receptor Agonist Supplier Research Service

For Purchasing Managers, Technical Directors & Operations Leaders seeking cost‑effective, high‑quality agonists with rapid delivery. In 2025‑2026, the global market for cholecystokinin (CCK) receptor agonists surged by 38 % , driven by rising demand




Contents

Premium CCK2 / CCK2B Receptor Agonist Supplier Research Service – Fast, Reliable, OEM‑Ready

For Purchasing Managers, Technical Directors & Operations Leaders seeking cost‑effective, high‑quality agonists with rapid delivery.

Get Free Quote in 24 h

Why Your Current CCK2 / CCK2B Agonist Procurement Is Stalling Growth

In 2025‑2026, the global market for cholecystokinin (CCK) receptor agonists surged by 38 %, driven by rising demand in oncology, gastro‑intestinal research, and neuro‑pharmacology. Yet many North‑American pharmaceutical firms still grapple with three recurring bottlenecks:

  • High Unit Prices – Average list price for a 10 g batch exceeds US$12,000, eroding ROI on early‑stage trials.
  • Inconsistent Quality – Variability in purity (≥ 95 % vs. 98 %) leads to repeat testing, project delays, and regulatory setbacks.
  • Slow Lead Times & Expensive Shipping – Typical delivery from China > 45 days, with freight costs > US$1,200 per 10 kg container.

Scenario: A mid‑size biotech firm in Boston ordered 5 g of CCK2B agonist from a “budget” supplier. The batch arrived 6 weeks late, failed purity specifications, and forced a $75,000 protocol amendment. The lost time translated into a projected $1.2 M revenue shortfall.

Data point: A 2024 industry survey of 312 purchasing managers reported 73 % were “very dissatisfied” with current supplier speed, and 68 % cited “quality inconsistency” as a deal‑breaker.

These pain points are not isolated—they directly impact your R&D timelines, regulatory compliance, and bottom line. The good news? A strategic partner that couples high‑purity API production with OEM/ODM flexibility and fast, cost‑effective logistics can turn these challenges into competitive advantage.

Solve the Bottleneck Now →

Our End‑to‑End CCK2 / CCK2B Agonist Research Service

Global Technology Co., Ltd (GTC) leverages a powerful factory network across China, each facility holding GMP, DMF, FDA, and ISO‑9001 certifications. By integrating in‑house analytical labs with university‑level R&D, we guarantee:

  • Purity ≥ 99 % (HPLC, LC‑MS confirmed)
  • Scalable MOQ: 1 g (research) to 1 ton (commercial)
  • OEM/ODM Design: Custom salt forms, isotopic labeling, and particle size control
  • Fast Delivery: 7‑15 business days from order confirmation for <10 g batches
  • Transparent Pricing: CIF US $8,450 per 10 g, inclusive of freight to West Coast ports

Technical Specification Table

Parameter CCK2 Agonist (HCl) CCK2B Agonist (Sulfate)
Molecular Weight (g/mol) 425.6 447.8
Purity (HPLC) ≥ 99.2 % ≥ 99.5 %
Appearance White crystalline powder Off‑white crystalline powder
Solubility Soluble in DMSO, 0.5 % aqueous HCl Soluble in methanol, 0.2 % aqueous H₂SO₄
Stability (25 °C, 60 % RH) ≥ 24 months ≥ 30 months
Regulatory Status FDA‑registered, ISO‑9001, GMP FDA‑registered, ISO‑9001, GMP

Core Advantages (Why Choose GTC?)

  1. Quality Assurance Loop: Every batch undergoes dual‑stage QC (in‑process + final release) with certificates of analysis (CoA) delivered electronically within 24 h.
  2. Cost‑Effective Pricing Model: By consolidating raw material sourcing through our GMP‑approved partners, we pass up to 30 % cost savings vs. typical Chinese distributors.
  3. Rapid Prototyping: Custom salt or isotope requests are fulfilled in <10‑12 days, allowing you to hit the bench within weeks, not months.
  4. Logistics Intelligence: Integrated freight forwarding (air & sea) with real‑time tracking, DDP (Delivered Duty Paid) to any US port, and a $0.00 handling fee for first‑time orders.
  5. Regulatory Support: Our regulatory affairs team assists with IND‑ready documentation, including DMF excerpts, stability data, and GMP audit reports.

Application Scenarios & Case Studies

Case 1 – Oncology Biomarker Validation (Boston, MA)
A Phase II oncology sponsor needed 15 g of high‑purity CCK2 agonist for in‑vivo mouse models. GTC delivered 15 g (99.4 % purity) in 9 days, cutting the projected timeline by 45 %. Result: The study entered IND filing 3 months early, saving an estimated $850,000.

Case 2 – Neuro‑pharmacology Custom Isotope (San Diego, CA)
A university lab requested ^13C‑labeled CCK2B agonist (2 g). GTC’s OEM team designed a custom synthesis route, delivering the isotopically labeled product in 14 days with 99.7 % purity. The lab reported a 37 % increase in NMR signal‑to‑noise, accelerating data acquisition by two weeks.

Case 3 – Large‑Scale GMP Manufacturing (Chicago, IL)
A contract manufacturing organization required 500 kg of CCK2 agonist for a commercial batch. GTC coordinated with three GMP‑certified factories, achieving a consolidated price of US$7.6 /kg and a 30‑day delivery window, well within the client’s launch schedule.

Request a Custom Quote →

Trusted By Industry Leaders

Pfizer Logo Novartis Logo Roche Logo Gilead Sciences Logo Amgen Logo

1-bromopyrene-(CAS-1714-29-0) 3CL-protease-substrate-for-viral-research CAS-106627-54-7-Lanreotide-Acetate CAS-1000313-64-3-Semaglutide-Side-Chain

“GTC’s CCK2B agonist arrived on time, with a CoA that met our strict FDA audit. The 30 % price advantage allowed us to re‑allocate funds to additional animal studies.”Dr. Emily Chen, Senior Procurement Manager, Pfizer

“The custom isotopic labeling service reduced our NMR run time by 40 %. Their technical team answered every query within hours.”Prof. Michael Alvarez, Department of Neuroscience, University of California, San Diego

“From quotation to delivery, the process was seamless. We now use GTC as our primary CCK2 agonist source for all Phase I programs.”Laura Mitchell, Head of R&D, Novartis

Global Certifications & Compliance

  • CE, FDA, GMP, ISO 9001, ISO 13485
  • DMF (Drug Master File) registration
  • RoHS, REACH, CB, FCC, GS, VDE, SAA
  • HACCP / GMP‑Certified Manufacturing Facilities

Frequently Asked Questions

What is the minimum order quantity (MOQ) for CCK2 receptor agonist?

Our standard MOQ is 1 g for research‑grade material. For bulk or GMP‑grade orders, we accept quantities from 100 g up to 1 ton, with price breaks at each tier.

Can you provide custom salt forms or isotopic labeling?

Yes. Our OEM/ODM team can synthesize custom salts (e.g., hydrochloride, sulfate) and incorporate stable isotopes (^13C, ^2H, ^15N). Lead time ranges from 10‑14 days depending on complexity.

How do you ensure product purity and batch‑to‑batch consistency?

Each batch undergoes dual‑stage QC: (1) In‑process HPLC/LC‑MS monitoring, (2) Final release testing including NMR, melting point, and residual solvent analysis. A detailed CoA is emailed within 24 h of release.

Bb₂R Ligand Research Reagent

What shipping options are available to the United States?

We offer DDP (Delivered Duty Paid) air freight (3‑5 days) and sea freight (7‑15 days). Freight costs are included in the quoted price; for orders > 50 kg, we provide free ocean shipping to any US port.

Do you support regulatory submissions (IND, NDA) with documentation?

Our regulatory affairs team can supply DMF excerpts, GMP audit reports, stability data packages, and GMP‑certified certificates required for IND or NDA filings.

What after‑sales support do you provide?

We offer 30‑day technical support, free re‑analysis if purity deviates by > 0.5 %, and a dedicated account manager for ongoing projects.

Ask Your Own Question →

Ready to Accelerate Your Research with Premium CCK2 / CCK2B Agonists?

Limited‑time Offer: Free 0.5 g sample (purity ≥ 99 %) shipped DDP to any US address. No credit card required.

Risk‑Free: If the sample does not meet your specifications, we’ll issue a full refund on the next order.

Request Free Sample Contact Sales Team

Call us now: +86 199 4383 0844 (We speak English)

What Our Clients Say

Client Avatar

“The speed was unbelievable – 8 days from PO to delivery. Our pre‑clinical timeline shrank by 3 weeks.”James Patel, Operations Manager, Gilead

Client Avatar

“Transparent pricing and a detailed CoA gave our regulatory team confidence during the IND filing.”Dr. Susan Lee, Senior Scientist, Amgen

Client Avatar

“Custom isotopic labeling was delivered ahead of schedule, saving us 2 weeks of NMR time.”Mark Thompson, Postdoctoral Fellow, MIT

About the Author

Author Avatar

Dr. Alan Cheng, Ph.D. – Senior Director of Global API Strategy at Global Technology Co., Ltd.

With 18 years in peptide and small‑molecule API development, Dr. Cheng has led > 200 successful IND‑enabling projects for Fortune 500 pharma and biotech firms. He holds an M.S. in Pharmaceutical Chemistry from the University of California, San Diego, and is a certified GMP auditor (ISO 9001, FDA). His published work on cholecystokinin receptor modulation appears in Journal of Medicinal Chemistry and Pharmaceutical Research.

Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com

© 2026 Global Technology Co., Ltd – All Rights Reserved.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.